Retour
Également cotée sous
EKTAF
OTC
Fourchette du Jour
5,92 €
5,99 €
Fourchette 52 Semaines
4,35 €
6,93 €
Volume
280
Moyenne 50J / 200J
6,29 €
/
5,45 €
Clôture Précédente
5,96 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 9,7 | 0,3 |
| P/B | 0,3 | 2,9 |
| ROE % | 2,4 | 3,7 |
| Net Margin % | 1,3 | 3,8 |
| Rev Growth 5Y % | 7,0 | 10,0 |
| D/E | 0,9 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
4,10 €
3,95 € – 4,40 €
|
18 B | 1 |
| FY2026 |
3,64 €
3,50 € – 3,90 €
|
17 B | 1 |
Points Clés
Revenue grew 6,96% annually over 5 years — modest growth
Earnings declined -81,80% over the past year
ROE of 2,42% is below average
Generating 1,06B in free cash flow
P/E of 9,66 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 7,53%
Croissance
Revenue Growth (5Y)
6,96%
Revenue (1Y)-0,57%
Earnings (1Y)-81,80%
FCF Growth (3Y)62,48%
Qualité
Return on Equity
2,42%
ROIC4,08%
Net Margin1,32%
Op. Margin4,94%
Sécurité
Debt / Equity
0,86
Current Ratio1,09
Interest Coverage2,14
Valorisation
P/E Ratio
9,66
P/B Ratio0,26
EV/EBITDA7,75
Dividend Yield0,05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0,57% | Revenue Growth (3Y) | 3,34% |
| Earnings Growth (1Y) | -81,80% | Earnings Growth (3Y) | -49,87% |
| Revenue Growth (5Y) | 6,96% | Earnings Growth (5Y) | -34,07% |
| Profitability | |||
| Revenue (TTM) | 18,02B | Net Income (TTM) | 237,00M |
| ROE | 2,42% | ROA | 0,82% |
| Gross Margin | 37,44% | Operating Margin | 4,94% |
| Net Margin | 1,32% | Free Cash Flow (TTM) | 1,06B |
| ROIC | 4,08% | FCF Growth (3Y) | 62,48% |
| Safety | |||
| Debt / Equity | 0,86 | Current Ratio | 1,09 |
| Interest Coverage | 2,14 | Dividend Yield | 0,05% |
| Valuation | |||
| P/E Ratio | 9,66 | P/B Ratio | 0,26 |
| P/S Ratio | 0,13 | PEG Ratio | -0,96 |
| EV/EBITDA | 7,75 | Dividend Yield | 0,05% |
| Market Cap | 2,29B | Enterprise Value | 6,90B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 18,02B | 18,12B | 16,87B | 14,55B | 13,76B |
| Net Income | 237,00M | 1,30B | 943,00M | 1,15B | 1,25B |
| EPS (Diluted) | 0,62 | 3,41 | 2,47 | 3,02 | 3,28 |
| Gross Profit | 6,75B | 6,80B | 6,35B | 5,44B | 5,61B |
| Operating Income | 890,00M | 2,04B | 1,43B | 1,64B | 1,91B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 28,98B | 31,41B | 29,61B | 26,30B | 24,84B |
| Total Liabilities | 20,13B | 20,63B | 19,88B | 17,39B | 16,65B |
| Shareholders' Equity | 8,80B | 10,78B | 9,73B | 8,91B | 8,20B |
| Total Debt | 7,57B | 7,25B | 6,67B | 5,70B | 6,24B |
| Cash & Equivalents | 2,96B | 2,77B | 3,27B | 3,07B | 4,40B |
| Current Assets | 13,42B | 13,96B | 14,38B | 12,88B | 13,25B |
| Current Liabilities | 12,35B | 14,00B | 12,71B | 11,56B | 11,94B |